JOURNAL OF CHEMICAL RESEARCH 2013 169
Scheme 1 The synthetic path of the target compounds 2a–l.
Table 1 Comparison of the yields and reaction times under
microwave irradiation and the conventional methods for
compounds 2a–l
7.86–7.01 (m, 12H), 4.23 (s, 2H); 13C NMR (50 MHz, DMSO-d6)
δ 196.4, 161.7 (d, J = 241.3), 157.2, 139.2, 138.8, 133.9, 132.7, 131.5,
131.2, 131.1, 129.1, 124.4, 118.5, 116.2, 115.4 (d, J = 4), 34.7. Anal.
Calcd for C21H15FN2O: C, 76.35; H, 4.58; N, 8.48. Found: C, 76.38; H,
4.55; N, 8.52%.
Compound
No.
MWI
Time/min
Conventional
Phenyl [2-(2-chlorobenzyl)-1H-1,3-benzimidazol-5-yl]methanone
Yield/% Time/min Yield/%
1
(2d): M.p. 198 °C, H NMR (200 MHz, DMSO-d6) δ 12.68 (s, 1H),
7.84–7.29 (m, 12H), 4.35 (s, 2H); 13C NMR (50 MHz, DMSO-d6)
δ 196.4, 155.5, 138.8, 135.84, 134.0, 132.7, 132.3, 131.0, 130.1,
130.0, 129.6, 129.1, 128.1, 124.6, 121.9, 118.8, 114.7, 111.9, 33.6.
Anal. Calcd for C21H15ClN2O: C, 72.73; H, 4.36; N, 8.08. Found: C,
72.75; H, 4.35; N, 8.04%.
2a
2b
2c
2d
2e
2f
2g
2h
2i
10
10
10
10
10
10
10
10
10
10
10
10
84
87
90
85
88
89
83
85
91
80
88
91
90
90
90
90
90
90
90
90
90
90
90
90
75
75
77
78
79
79
77
78
78
75
78
79
Phenyl [2-(3-chlorobenzyl)-1H-1,3-benzimidazol-5-yl]methanone
(2e): M.p. 231 °C, 1H NMR (200 MHz, DMSO-d6) δ 12.01 (bs, 1H),
7.89–7.33 (m, 12H), 4.30 (s, 2H); 13C NMR (50 MHz, DMSO-d6)
δ 196.3, 156.5, 141.7, 139.8, 138.7, 138.3, 133.8, 132.8, 131.6, 131.2,
130.2, 129.5, 129.1, 128.5, 127.6, 124.8, 118.4, 115.1, 34.8. Anal.
Calcd for C21H15ClN2O: C, 72.73; H, 4.36; N, 8.08. Found: C, 72.76;
H, 4.34; N, 8.06%.
2j
2k
2l
Phenyl [2-(4-chlorobenzyl)-1H-1,3-benzimidazol-5-yl]methanone
1
(2f): M.p. 259 °C, H NMR (200 MHz, DMSO-d6) δ 12.71 (s, 1H),
7.99–7.37 (m, 12H), 4.23 (s, 2H); 13C NMR (50 MHz, DMSO-d6)
δ 196.4, 156.9, 141.5, 138.8, 136.7, 132.7, 132.1, 131.5, 131.2, 130.1,
129.2, 129.1, 124.4, 118.7, 115.5, 34.9. Anal. Calcd for C21H15ClN2O:
C, 72.73; H, 4.36; N, 8.08. Found: C, 72.74; H, 4.35; N, 8.10%.
Phenyl [2-(2-bromobenzyl)-1H-1,3-benzimidazol-5-yl]methanone
(2g): M.p. 210 °C, 1H NMR (200 MHz, DMSO-d6) δ 12.66 (bs, 1H),
7.86–7.24 (m, 12H), 4.37 (s, 2H); 13C NMR (50 MHz, DMSO-d6)
δ 196.4, 156.1, 138.8, 137.1, 133.3, 132.7, 132.4, 131.1, 130.2, 129.8,
129.1, 128.7, 124.9, 124.4, 118.4, 115.2, 36.2. Anal. Calcd for
C21H15BrN2O: C, 64.46; H, 3.86; N, 7.16. Found: C, 64.50; H, 3.84; N,
7.18%.
flask. The solution was stirred for 1.5 h at room temperature. After
completion of the reaction (monitored by TLC, ethylacetate:hexane,
3:1), the mixture was poured into water and neutralised with sodium
bicarbonate. The precipitate was collected by filtration and recrystal-
lised from ethanol–water (1:3) to give pure 2a–l.
Microwave method: A mixture of corresponding iminoester hydro-
chlorides (1a–l) (0.012 mol), HCl (2 mL) and 3,5-diaminobenzophe-
none (0.01 mol) in dry methanol (15 mL) was irradiated in closed
vessels with pressure control at 65 °C for 10 min. (hold time) at
300 W maximum power. The above purification methods were used to
give pure products 2a–l.
Phenyl [2-(3-bromobenzyl)-1H-1,3-benzimidazol-5-yl]methanone
Phenyl [2-(2-fluorobenzyl)-1H-1,3-benzimidazol-5-yl]methanone
(2a): M.p. 185 °C, 1H NMR (200 MHz, DMSO-d6) δ 12.09 (bs, 1H),
8.01–7.23 (m, 12H), 4.66 (s, 2H); 13C NMR (50 MHz, DMSO-d6)
δ 194.7, 160.2 (d, J = 244), 153.8, 136.8, 134.0, 133.8, 132.7, 131.8,
131.0, 130.2, 129.6, 128.5, 126.7, 124.9, 120.5 (d, J = 15.4), 116.0,
115.8, 114.7 (d, J = 61.5), 104.2, 26.1. Anal. Calcd for C21H15FN2O:
C, 76.35; H, 4.58; N, 8.48. Found: C, 76.37; H, 4.54; N, 8.50%.
Phenyl [2-(3-fluorobenzyl)-1H-1,3-benzimidazol-5-yl]methanone
1
(2h): M.p. 175 °C, H NMR (200 MHz, DMSO-d6) δ 12.59 (s, 1H),
7.88–7.28 (m, 12H), 4.26 (s, 2H); 13C NMR (50 MHz, DMSO-d6)
δ 196.4, 156.6, 142.7, 140.4, 139.3, 139.2, 138.8, 132.7, 132.3, 131.4,
131.2, 130.3, 130.1, 129.0, 128.7, 124.4, 122.4, 118.6, 155.1, 35.1.
Anal. Calcd for C21H15BrN2O: C, 64.46; H, 3.86; N, 7.16. Found: C,
64.50; H, 3.84; N, 7.18%.
Phenyl [2-(4-bromobenzyl)-1H-1,3-benzimidazol-5-yl]methanone
1
1
(2i): M.p. 189 °C, H NMR (200 MHz, DMSO-d6) δ 12.72 (s, 1H),
(2b): M.p. 248 °C, H NMR (200 MHz, DMSO-d6) δ 12.03 (s, 1H),
7.87–7.29 (m, 12H), 4.26 (s, 2H); 13C NMR (50 MHz, DMSO-d6)
δ 196.4, 156.7, 140.5, 138.8, 132.7, 132.3, 131.4, 131.2, 130.3, 130.2,
129.1, 129.0, 128.8, 124.4, 122.4, 118.7, 155.2, 35.1. Anal. Calcd for
C21H15BrN2O: C, 64.46; H, 3.86; N, 7.16. Found: C, 64.45; H, 3.85; N,
7.14%.
8.01–7.12 (m, 12H), 4.62 (s, 2H); 13C NMR (50 MHz, DMSO-d6)
δ 195.5, 162.9 (d, J = 242.5), 155.2, 137.6, 137.0, 136.9, 134.7, 133.6,
131.8, 131.6, 131.5, 130.4, 130.3, 129.3, 127.5, 126.3, 117.1 (d,
J = 22.3), 115.6, 115.1 (d, J = 61.5), 32.5.Anal. Calcd for C21H15FN2O:
C, 76.35; H, 4.58; N, 8.48. Found: C, 76.36; H, 4.56; N, 8.51%.
Phenyl [2-(4-fluorobenzyl)-1H-1,3-benzimidazol-5-yl]methanone
Phenyl [2-(2-methylbenzyl)-1H-1,3-benzimidazol-5-yl]methanone
1
1
(2j): M.p. 190 °C, H NMR (200 MHz, DMSO-d6) δ 12.61 (s, 1H),
(2c): M.p. 231 °C, H NMR (200 MHz, DMSO-d6) δ 11.93 (s, 1H),